NMPA Approval

Cerebroprotein Hydrolysate Injection

Approval Number

国药准字H22024509

Company吉林敖东药业集团延吉股份有限公司

Registration Date

December 31, 2021

Previous Approval Numbers

国药准字H22024509

Drug Information

Generic Name

脑蛋白水解物注射液

Dosage Form

注射剂

Strength

5ml

Drug Type

化学药品

Registration Date

December 31, 2021

Company Information

Applicant Company

Company Name吉林敖东药业集团延吉股份有限公司

Company Address

吉林省延吉市高新技术开发区长白路389号

Manufacturing Company

Company Name吉林敖东药业集团延吉股份有限公司

Company Address

吉林省延吉市高新技术开发区长白路389号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.